Congratulations to Astia portfolio company Aralez Bio on the announcement of their $17.5M award with Resilience to fund innovative biomanufacturing of active pharmaceutical ingredients #inclusion #innovation #investment #portfolio
Aralez Bio and Resilience have secured a $17.5M award to fund innovative biomanufacturing of active pharmaceutical ingredients in the United States. This award was made by HHS Administration for Strategic Preparedness and Response (ASPR) through the BioMaP-Consortium | Biopharmaceutical Manufacturing Preparedness Consortium, a public-private partnership that aims to ensure the availability of life-saving medicines currently in drug shortage. The funding will enable cGMP manufacturing using Aralez Bio’s cutting-edge enzyme platform to streamline production of active pharmaceutical ingredients made within the United States, including submitting the necessary data to the FDA for Resilience to become an approved domestic API supplier. Read more here 🔗: https://lnkd.in/gfTebDDi #AralezBio #BeNoncanonical #Biotech #Pharma #Funding #SupplyChain #Innovation